Silver Book Fact

Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.

Pearson, Thomas. The Prevention Of Cardiovascular Disease: Have we really made progress?. Health Affairs. 2007; 26(1): 49-60

Reference

Title
The Prevention Of Cardiovascular Disease: Have we really made progress?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Pearson, Thomas
Volume & Issue
Volume 26, Issue 1
Pages
49-60

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • There are 23 medicines in development for stroke, the third leading cause of death after heart disease and cancer.  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • The percentage of Americans age 55-64 with high cholesterol decreased between 1988-94 and 1999-2002, in part because of the increased awareness about the risks of high cholesterol and the increased…  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.